Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical and LAT1 Biomarker Correlates of Clinical Benefit from Nanvuranlat (JPH203) in Advanced Biliary Tract Cancer: A Post Hoc Analysis.
Journal: Cancers
Published: July 02, 2026
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.
Journal: The Lancet. Oncology
Published: September 19, 2023
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.
Journal: Investigational new drugs
Published: February 12, 2020
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: November 27, 2017
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.
Journal: Cell
Published: August 25, 2017
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells.
Journal: Leukemia
Published: February 03, 2015
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
Journal: Haematologica
Published: November 09, 2014
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.
Journal: Blood
Published: May 27, 2014
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia.
Journal: British journal of haematology
Published: February 26, 2014
A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2007
Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 20, 2005
Showing 1-12 of 12
Last Updated: 09/26/2026